LENZ Therapeutics Inc (LENZ NASDAQ) stock market data APIs
$10.0103
-0.15(-1.5%)
as of May 8, 2026
Try our APIs with
free plan!
LENZ Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
Prev. Close
10.0103
Open
9.8574
High
10.0386
Low
9.5842
52 wk Range
8.25-50.4
Market Cap
315 M
Shares Outstanding
31 354 K
Revenue
19 088 K
EPS
-1.16
Beta
1.669
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with LENZ Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get LENZ Therapeutics Inc data using free add-ons & libraries
Get LENZ Therapeutics Inc Fundamental Data
LENZ Therapeutics Inc Fundamental data includes:
- Net Revenue: 19 088 K
- EBITDA: -90 851 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-12-31
- EPS/Forecast: -0.924
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
LENZ Therapeutics Inc News
New
Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week
According to data compiled by S&P Global Market Intelligence, Lenz Therapeutics(NASDAQ: LENZ) fell by just under 20% over the course of this trading week. Investors were in a bearish mood following a ...
LENZ Therapeutics, Inc. Q4 2025 Earnings Call Summary
LENZ Therapeutics, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Market Dynamics Management attributes early success to real-world clinical performance matching trial data, with ...
LENZ Therapeutics Q4 Earnings Call Highlights
LENZ Therapeutics logo Executives from LENZ Therapeutics (NASDAQ:LENZ) used the company’s latest earnings call to provide an update on the early U.S. launch of its presbyopia eye drop, emphasizing ...
Why Lenz Therapeutics Stock Crashed Today
Lenz Therapeutics(NASDAQ: LENZ) stock tumbled 11.2% through 9:50 a.m. ET Tuesday after missing on Q4 earnings. Heading into the report, analysts forecast Lenz to lose $0.90 per share on quarterly sal...
Get LENZ Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
